250 related articles for article (PubMed ID: 16615003)
1. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.
Konturek PC; Rembiasz K; Burnat G; Konturek SJ; Tusinela M; Bielanski W; Rehfeld J; Karcz D; Hahn E
Dig Dis Sci; 2006 Apr; 51(4):779-87. PubMed ID: 16615003
[TBL] [Abstract][Full Text] [Related]
2. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
3. Progastrin and cyclooxygenase-2 in colorectal cancer.
Konturek PC; Bielanski W; Konturek SJ; Hartwich A; Pierzchalski P; Gonciarz M; Marlicz K; Starzynska T; Zuchowicz M; Darasz Z; Götze JP; Rehfeld JF; Hahn EG
Dig Dis Sci; 2002 Sep; 47(9):1984-91. PubMed ID: 12353842
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer.
Hartwich A; Konturek SJ; Pierzchalski P; Zuchowicz M; Labza H; Konturek PC; Karczewska E; Bielanski W; Marlicz K; Starzynska T; Lawniczak M; Hahn EG
Int J Colorectal Dis; 2001 Aug; 16(4):202-10. PubMed ID: 11515678
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
Konturek PC; Hartwich A; Zuchowicz M; Labza H; Pierzchalski P; Karczewska E; Bielanski W; Hahn EG; Konturek SJ
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):737-49. PubMed ID: 11192946
[TBL] [Abstract][Full Text] [Related]
7. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
8. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.
Siddheshwar RK; Gray JC; Kelly SB
Gut; 2001 Jan; 48(1):47-52. PubMed ID: 11115822
[TBL] [Abstract][Full Text] [Related]
10. Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration.
Konturek SJ; Konturek PC; Plonka A; Duda A; Sito E; Zuchowicz M; Hahn EG
Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):39-51. PubMed ID: 11519793
[TBL] [Abstract][Full Text] [Related]
11. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells.
Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ
J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216
[TBL] [Abstract][Full Text] [Related]
12. PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
Lachal S; Ford J; Shulkes A; Baldwin GS
Regul Pept; 2004 Aug; 120(1-3):243-51. PubMed ID: 15177943
[TBL] [Abstract][Full Text] [Related]
13. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
14. Progastrin: a potential predictive marker of liver metastasis in colorectal cancer.
Westwood DA; Patel O; Christophi C; Shulkes A; Baldwin GS
Int J Colorectal Dis; 2017 Jul; 32(7):1061-1064. PubMed ID: 28432443
[TBL] [Abstract][Full Text] [Related]
15. Control of tissue progastrin concentrations in the rat.
Varro A; Yegen B; Dockray GJ
Exp Physiol; 1993 May; 78(3):327-36. PubMed ID: 8329207
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer.
Konturek PC; Konturek SJ; Sulekova Z; Meixner H; Bielanski W; Starzynska T; Karczewska E; Marlicz K; Stachura J; Hahn EG
Aliment Pharmacol Ther; 2001 Jul; 15(7):989-99. PubMed ID: 11421874
[TBL] [Abstract][Full Text] [Related]
17. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
18. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.
Subramaniam D; Ramalingam S; May R; Dieckgraefe BK; Berg DE; Pothoulakis C; Houchen CW; Wang TC; Anant S
Gastroenterology; 2008 Apr; 134(4):1070-82. PubMed ID: 18395088
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]